User menu

Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos.

Bibliographic reference Petrek, Martin ; Hermans, Cédric ; Kolek, Vítĕzslav ; Fialová, Jarmila ; Bernard, Alfred. Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos.. In: Biomarkers, Vol. 7, no.1, p. 58-67 (2002 Jan-Feb)
Permanent URL http://hdl.handle.net/2078/125196
  1. Becklake Margaret R., Asbestos and Other Fiber-Related Diseases of the Lungs and Pleura, 10.1378/chest.100.1.248
  2. Bégin R., Cantin A., Berthiaume Y., Boileau R., Bisson G., Lamoureux G., Rola-Pleszczynski M., Drapeau G., Massé S., Boctor M., Breault J., Péloquin S., Dalle D., Clinical features to stage alveolitis in asbestos workers, 10.1002/ajim.4700080604
  3. Bernard A. M., Clinical Chemistry, 29, 1007 (1983)
  4. Bernard Alfred, Lauwerys Robert, Noel André, Vandeleene Bernard, Lambert André, Determination by latex immunoassay of protein 1 in normal and pathological urine, 10.1016/0009-8981(91)90374-l
  5. Bernard A., European Respiratory Journal, 5, 1231 (1992)
  6. Bernard A.M., Roels H.A., Buchet J.P., Lauwerys R.R., Serum Clara Cell Protein: An Indicator of Bronchial Cell Dysfunction Caused by Tobacco Smoking, 10.1006/enrs.1994.1047
  7. Bernard A. M., European Respiratory Journal, 7, 1932 (1994)
  8. Bernard A, Hermans C, Van Houte G, Transient increase of serum Clara cell protein (CC16) after exposure to smoke., 10.1136/oem.54.1.63
  9. Brody A. R., Federation Proceedings, 44, 2596 (1985)
  10. Broeckaert F, Arsalane K, Hermans C, Bergamaschi E, Brustolin A, Mutti A, Bernard A, Lung epithelial damage at low concentrations of ambient ozone, 10.1016/s0140-6736(99)00540-1
  11. Broser Mindy, Zhang Yihong, Aston Christopher, Harkin Timothy, Rom William N., Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure, 10.1007/bf00381242
  12. Doll R., British Journal of Industrial Medicine, 12, 81 (1955)
  13. Doyle I. R., American Journal of Respiratory and Critical Care Medicine, 158, 1528 (1998)
  14. Gellert A. R., American Review of Respiratory Diseases, 132, 824 (1985)
  15. Green F H, Harley R, Vallyathan V, Althouse R, Fick G, Dement J, Mitha R, Pooley F, Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers., 10.1136/oem.54.8.549
  16. Hermans Cedric, Bernard Alfred, Clara cell protein (CC16): characteristics and potential applications as biomarker of lung toxicity, 10.3109/13547509609079341
  17. Hermans C., Bernard A., Pneumoproteinaemia: a new perspective in the assessment of lung disorders, 10.1183/09031936.98.11040801
  18. Hermans C., American Journal of Respiratory and Critical Care Medicine, 159, 646 (1999)
  19. Hermans Cedric, Aly Osman, Nyberg Britt-Inger, Peterson Christer, Bernard Alfred, Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays, 10.1016/s0009-8981(98)00006-0
  20. Hurbankova M., Studia Pneumologica Phtiseologica, 59, 99 (1999)
  21. Kolek V., Pracovni Lekarstvi, 48, 79 (1996)
  22. Lesur O, Bernard A, Arsalane K, Lauwerys R, Bégin R, Cantin A, Lane D, Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro., 10.1164/ajrccm.152.1.7541278
  23. Lesur Olivier, Bernard Alfred M., Bégin Raymond O., Clara Cell Protein (CC-16) and Surfactant-Associated Protein A (SP-A) in Asbestos-Exposed Workers, 10.1378/chest.109.2.467
  24. Majurin M.-L., Varpula M., Kurki T., Pakkala L., High-Resolution Ct of the Lung in Asbestos-Exposed Subjects : Comparison Of Low-Dose And High-Dose Hrct, 10.1080/02841859409174340
  25. Mossman Brooke T., Gee J. Bernard L., Asbestos-Related Diseases, 10.1056/nejm198906293202604
  26. Mossman B. T., American Journal of Respiratory and Critical Care Medicine, 157, 1666 (1998)
  27. Mysliveček M., Hušák V., Kolek V., Budíková M., Koranda P., Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis, 10.1007/bf00180862
  28. Nair P., Sarcoidosis, 8, 115 (1991)
  29. Peng L., British Journal of Industrial Medicine, 50, 183 (1993)
  30. Peterson M. W., American Journal of Physiology, 265, L308 (1993)
  31. Petrek M., Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 129, 51 (1991)
  32. Quinlan T. R., American Journal of Pathology, 147, 728 (1995)
  33. Rinderknecht J., American Review of Respiratory Diseases, 121, 105 (1985)
  34. Rom William N., Travis William D., Lymphocyte-Macrophage Alveolitis in Nonsmoking Individuals Occupationally Exposed to Asbestos, 10.1378/chest.101.3.779
  35. Rosenthal G. J., Reviews on Environmental Health, 14, 11 (1999)
  36. Schwartz D. A., American Journal of Respiratory and Critical Care Medicine, 150, 1243 (1994)
  37. Shijubo N., Itoh Y., Yamaguchi T., Shibuya Y., Morita Y., Hirasawa M., Okutani R., Kawai T., Abe S., Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers, 10.1183/09031936.97.10051108
  38. Singh G., American Journal of Respiratory Cell and Molecular Biology, 17, 141 (1997)
  39. Teschler H., American Review of Respiratory Diseases, 147, 1211 (1993)
  40. Teschler H., Thompson A.B., Dollenkamp R., Konietzko N., Costabel U., Relevance of asbestos bodies in sputum, 10.1183/09031936.96.09040680
  41. Trošić Ivančica, Pišl Zoran, Consequences of long-lasting asbestos-exposure: Peripheral blood parameters in shipyard workers with and without asbestosis, 10.1016/s0940-2993(11)80317-9
  42. Wagner Gregory R, Asbestosis and silicosis, 10.1016/s0140-6736(96)07336-9
  43. Zhang Y., Journal of Immunology, 150, 4188 (1993)